Why These 4 Stocks Have Started the Week Off on the Right Foot
The markets have continued to tumble in the second week of 2016, with all major U.S stock indexes now down today after a mild rally earlier in the day.
Amag Pharmaceuticals Inc. (AMAG)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Do Hedge Funds Love AMAG Pharmaceuticals, Inc. (AMAG)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
The Shoddy Results That Have These Four Stocks Plunging Today
The shareholders of CIT Group Inc. (NYSE:CIT), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), Avis Budget Group Inc.
Should You Follow This Investor Into His Biotech Picks?
For the last year or so, many investors have been seeking profitable opportunities in the biotech sector, which has sent the shares of many stocks higher.
These Hot Healthcare Stocks Lead Palo Alto Investors' Picks To Big Q2 Returns
William Leland Edwards' Palo Alto Investors is a reputable fund with a strong focus and in-depth knowledge of healthcare stocks, a sector that accounts for more than 80% of its total holdings.
Volcano Corporation (VOLC), Relypsa Inc (RLYP), Inogen Inc (INGN):5 Small-Cap Healthcare Stocks Hedge Funds Are Flocking To
Our research has shown us that hedge funds are particularly adept at generating large returns from small-cap stocks.
AMAG Pharmaceuticals Inc. (AMAG): Deerfield Management Boosts Stake to Nearly 6%
Deerfield Management, managed by James E. Flynn, has disclosed upping its stake in AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). A new filing with the U.S.
Broadfin Capital Initiates New Positions In Corium International Inc (CORI), AMAG Pharmaceuticals Inc. (AMAG) and La Jolla Pharmaceutical Company (LJPC)
In three recent filings, Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals Inc.
Visium Asset Management’s Latest Purchase: AMAG Pharmaceuticals Inc. (AMAG)
Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc.
Meridian Bioscience, Inc. (VIVO): Are Hedge Funds Right About This Stock?
In the 21st century investor’s toolkit, there are many methods shareholders can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
